Clinical Trials Browser

Interventional × eltrombopag × Other hematologic neoplasm × Clear all

NCT06630221 2026-06-05

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Phase 2 Suspended

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT03948529 2025-09-30

REGALIA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia

NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Phase 4 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT03603795 2024-10-29

EPAG2015

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02446145 2024-03-29

DELTA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

Phase 2/3 Completed

21 enrolled 10 charts

Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

NCT01772420 2023-07-27

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Phase 2 Completed

52 enrolled 21 charts

Classical hematologyOther hematologic neoplasm

Anemia, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

NCT01168921 2023-03-23

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

23 enrolled 9 charts

Classical hematologyLymphoidOther hematologic neoplasm

Jacobs syndrome, Leukemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Phase 4 Completed

22 enrolled 9 charts

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Terminated

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT02071901 2021-12-01

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Phase 2 Unknown

31 enrolled 14 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01113502 2021-08-05

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

Phase 1/2 Terminated

44 enrolled 16 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02323178 2021-04-20

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

Phase 1/2 Completed

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

NCT01656252 2020-11-03

PrE0901

Phase 1/2 Terminated

15 enrolled 5 charts

Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT01893372 2020-02-18

Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

Phase 2 Completed

29 enrolled 12 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

NCT02010645 2020-01-02

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Phase 2 Terminated

6 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Chronic

NCT01890746 2019-09-11

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Phase 2 Completed

148 enrolled 42 charts

Classical hematologyOther hematologic neoplasm

Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT03701217 2018-10-09

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Phase 2/3 Unknown

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myeloid, Acute

NCT01610180 2018-07-16

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Purpura, Thrombocytopenic, Idiopathic

NCT01440374 2017-06-05

ASPIRE

Phase 2 Completed

162 enrolled 24 charts

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT01488565 2016-02-15

Aza-E

Phase 2 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01757145 2015-06-19

Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation

Phase 2 Unknown

Other hematologic neoplasm

Bone Marrow Failure Disorders, Hematologic Neoplasms

NCT01397149 2015-05-28

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Phase 1/2 Terminated

Classical hematologyLymphoidOther hematologic neoplasm

Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell